- Home
- ALLR vs XOS Comparison
ALLR vs XOS Comparison
Compare ALLR & XOS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | ALLR | XOS |
|---|---|---|
| Founded | 2004 | 2016 |
| Country | United States | United States |
| Employees | N/A | 101 |
| Industry | Biotechnology: Pharmaceutical Preparations | Construction/Ag Equipment/Trucks |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 19.3M | 22.8M |
| IPO Year | 2021 | N/A |
Fundamental Metrics
Financial Performance| Metric | ALLR | XOS |
|---|---|---|
| Price | $1.73 | $2.06 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 1 | 1 |
| Target Price | ★ $9.75 | $7.00 |
| AVG Volume (30 Days) | ★ 212.0K | 166.5K |
| Earning Date | 05-15-2026 | 05-13-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $320,000.00 | N/A |
| Revenue This Year | N/A | $29.02 |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $0.77 | $1.60 |
| 52 Week High | $2.35 | $5.60 |
Technical Indicators
Market Signals| Indicator | ALLR | XOS |
|---|---|---|
| Relative Strength Index (RSI) | 67.92 | 60.31 |
| Support Level | $0.92 | $1.70 |
| Resistance Level | $1.79 | $2.15 |
| Average True Range (ATR) | 0.17 | 0.17 |
| MACD | 0.01 | 0.02 |
| Stochastic Oscillator | 93.98 | 71.96 |
Price Performance
Historical ComparisonAbout ALLR Allarity Therapeutics Inc.
Allarity Therapeutics Inc is a clinical-stage, precision medicine pharmaceutical company focused on developing novel anti-cancer therapeutics for patients with high unmet medical needs. The company is actively advancing the development of stenoparib, an orally available, small-molecule inhibitor for patients with advanced recurrent ovarian cancer. It is leveraging its proprietary Drug Response Predictor (DRP) technology to refine patient selection and improve clinical outcomes. The company operates as a single operating and reporting segment (developing a treatment for ovarian cancer) in two geographic areas: Denmark and the United States.
About XOS Xos Inc.
Xos Inc is a fleet electrification solutions provider committed to the decarbonization of commercial transportation. Xos designs and manufactures Class 5 through 8 battery-electric commercial vehicles that travel on last-mile, back-to-base routes of up to 200 miles per day. Xos also offers charging infrastructure products and services through Xos Energy Solutions to support electric vehicle fleets. Its products include Stepvan, MDXT, HDXT, Xosphere, and Xos Energy Solutions.